23andMe. Photo: Eric Baradat/AFP/Getty Images

23andMe is best known for its home DNA-testing kits, but it also wants to become a pharmaceutical company.

Driving the news: 23andMe is doing early research on 13 compounds, which could ultimately treat skin conditions, cancer and heart disease, Business Insider reports (subscription required).

  • The company has 70 scientists working on those compounds, plus 2 more potential drugs that are further along in the process.
  • And all of that comes on top of 23andMe's partnership with established drugmakers. It struck a $300 million deal with GlaxoSmithKline last year.

The intrigue: The overwhelming majority of efforts to create a new drug end in failure. But 23andMe is hoping its vast stores of human DNA information will give it a better shot, per Business Insider.

Go deeper

Updated 2 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Eniola Odetunde/Axios

  1. Global: Total confirmed cases as of 11 a.m. ET: 34,026,003 — Total deaths: 1,015,107 — Total recoveries: 23,680,268Map.
  2. U.S.: Total confirmed cases as of 11 a.m. ET: 7,237,043 — Total deaths: 207,008 — Total recoveries: 2,840,688 — Total tests: 103,939,667Map.
  3. Health: New poll shows alarming coronavirus vaccine skepticism — New research centers will study "long-haul" COVID — Coronavirus infections rise in 25 states.
  4. Business: Remdesivir is good business for Gilead.
  5. Transportation: The politics of pandemic driving.
  6. 🎧Podcast: The looming second wave of airline layoffs.
Dan Primack, author of Pro Rata
2 hours ago - Economy & Business

The new guinea pig in the Silicon Valley culture war

Illustration: Annelise Capossela/Axios

Coinbase this week offered severance packages to employees who don't feel aligned with the company’s apolitical culture and mission, which CEO Brian Armstrong clarified Sunday in a blog post.

Why it matters: The crypto company, most recently valued by investors at over $8 billion, is setting itself up as a guinea pig in a culture battle that's more about stereotypical Silicon Valley vs. stereotypical Wall Street than it is about progressives vs. libertarians.

3 hours ago - Technology

Senate panel votes to subpoena Big Tech CEOs

Photo: Graeme Jennings/Pool via Getty Images

The Senate Commerce Committee has voted to authorize subpoenas compelling Facebook CEO Mark Zuckerberg, Twitter CEO Jack Dorsey and Google CEO Sundar Pichai to testify before the panel.

Why it matters: The tech giants are yet again facing a potential grilling on Capitol Hill sometime before the end of the year, at a time when tech is being used as a punching bag from both the left and right.